We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Metabolon Awarded U.S. Patent for Determining Metabolic Age of an Individual


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Metabolon Awarded U.S. Patent for Determining Metabolic Age of an Individual"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 
Metabolon, Inc., announces the grant of US Patent 7,781,160 entitled “Biomarkers Related to Metabolic Age and Methods Using the Same”. The USPTO awarded the patent to Metabolon on August 24, 2010. This is the 12th patent issued to Metabolon.

As more information regarding the impact of nutrition on health-related issues becomes available and as the population ages, interest in health and nutrition has increased. The metabolism of an individual changes with age. Until recently the ability to monitor metabolite changes has been limited to targeted assays. With the development of metabolomics analysis, changes in metabolites can now be monitored globally in a non-targeted manner. This metabolomic approach allows a metabolic profile to be determined for a group or an individual. The patented invention provides biomarkers and methods to determine the metabolic age of an individual. The ability to determine the metabolite levels of an individual and classify the resulting metabolic profile as positive or negative and then to provide guidance as to how to improve a negative profile will have beneficial effects on the health of an individual.

Metabolon is the exclusive license holder of the Daouk-Kristal patent family which is comprised of early, pioneering patents and patent applications which provide fundamental IP in the field of metabolomics.
Advertisement